dc.contributor.author | Arokiasamy, S | en_US |
dc.contributor.author | Balderstone, MJM | en_US |
dc.contributor.author | De Rossi, G | en_US |
dc.contributor.author | Whiteford, JR | en_US |
dc.date.accessioned | 2020-02-10T15:13:07Z | |
dc.date.available | 2019-12-10 | en_US |
dc.date.issued | 2020-01-09 | en_US |
dc.identifier.issn | 1664-3224 | en_US |
dc.identifier.other | ARTN 3031 | |
dc.identifier.other | ARTN 3031 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/62712 | |
dc.language.iso | en | en_US |
dc.relation.ispartof | FRONTIERS IN IMMUNOLOGY | en_US |
dc.rights | Creative Commons Attribution License (CC BY). | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | heparan sulfate | en_US |
dc.subject | syndecan | en_US |
dc.subject | HIV | en_US |
dc.subject | rheumatoid arthritis | en_US |
dc.subject | angiogenesis | en_US |
dc.title | Syndecan-3 in Inflammation and Angiogenesis | en_US |
dc.type | Article | |
dc.rights.holder | © 2020 Arokiasamy, Balderstone, De Rossi and Whiteford. | |
dc.identifier.doi | 10.3389/fimmu.2019.03031 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000508892900001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 10 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |